RPRX
Repros Therapeutics Inc.
RPRX
RPRX
Delisted
RPRX was delisted on the 31st of January, 2018.
79 hedge funds and large institutions have $412M invested in Repros Therapeutics Inc. in 2013 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 31 increasing their positions, 24 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
50% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 26
Holders
79
Holding in Top 10
2
Calls
$17.7M
Puts
$11.8M
Top Buyers
| 1 | +$18.4M | |
| 2 | +$17.2M | |
| 3 | +$14.4M | |
| 4 |
PC
PointState Capital
New York
|
+$4.94M |
| 5 |
Jennison Associates
New York
|
+$4.68M |
Top Sellers
| 1 | -$25.8M | |
| 2 | -$11.9M | |
| 3 | -$11.4M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6.95M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$3.96M |